Trial intelligence / Profile preview

Financial Incentives and NRT for Smoking Cessation in Mothers

NCT05740098Completed

Sponsor
The University of Vermont
Start
Jun 2015
Primary completion
Dec 2019
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of nicotine in Tobacco Use Disorder (TUD) (3 arms), sponsored by The University of Vermont. Primary endpoints: 7-day Point Prevalence Smoking Abstinence Levels at 24 weeks and Objective Measure of Child Secondhand Smoke Exposure (SHSe) at 24 weeks. Started Jun 2015; status: completed.

02

Drugs

nicotine
03

Conditions

Tobacco Use Disorder (TUD)

Beyond the preview

Go deeper on NCT05740098.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05740098.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call